Mitsui to close several Japanese plants and expand in China


Japanese firm Mitsui Chemicals is planning to shut down operations at several sites, while expanding others in an effort to become more profitable. The company is moving away from commodity isocyanate and phenolic chemicals that are currently oversupplied in Asia, and concentrating on xylene diisocyanate (XDI) and other specialities for which it is the main supplier. It is also aiming to decrease exports to China, which have been devalued by the weakness of the Yen, and establish new production plants in China to compete in the growing local market.

Mitsui will completely close its Kashima works, as well as the phenol and bisphenol A plants owned by its Chiba Phenol joint venture with Idemitsu Kosan. Mitsui will also cease its Japanese production of diphenylmethane diisocyanate (MDI) at Omuta, and convert that site to produce larger volumes of speciality isocyanates including XDI. The company will continue to produce toluene diisocyanate (TDI) at Omuta, and MDI through its Korean subsidiary.

To combat the high export duties and transport costs of shipping phenols from Japan to China, Mitsui intends to build a large scale phenols plant in China to compete in the local market, in partnership with Chinese chemicals giant Sinopec.


Related Content

Business roundup

29 July 2010 Business

news image

Industry news, August 2010

Chemistry in bloom

23 September 2014 Feature

news image

Sarah Houlton discovers the chemistry among the specimens at many botanical gardens

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Grad student blamed for research misconduct at Utah

13 November 2014 News and Analysis

news image

Two papers have been retracted due to image falsification at the University of Utah

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company